Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients

Authors


  • Conflicts of interest: Dr Bentivoglio has received research funding for research activities from Chiesi Pharmaceutics, Merz, UCB Pharma, Ipsen, Allergan, Novartis, and speaker's fee from different providers in meetings sponsored by Chiesi Pharmaceutics, Merz, UCB Pharma, Ipsen, Allergan, Novartis. Dr Capone, Dr Profice, Dr Pilato, Dr Ialongo, Dr Di Giacopo, Prof Di Lazzaro reported no biomedical financial interests or potential conflicts of interest.

Correspondence: Vincenzo Di Lazzaro, Institute of Neurology Campus Bio-Medico University, Via Alvaro del Portillo, 200, 00128 Rome, Italy.

E-mail: v.dilazzaro@unicampus.it

No abstract is available for this article.

Ancillary